Form 8-K - Current report:
SEC Accession No. 0001641172-25-012536
Filing Date
2025-05-28
Accepted
2025-05-27 17:37:56
Documents
12
Period of Report
2025-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 35607
  Complete submission text file 0001641172-25-012536.txt   204576

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE shph-20250521.xsd EX-101.SCH 3030
3 XBRL LABEL FILE shph-20250521_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE shph-20250521_pre.xml EX-101.PRE 24175
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41488 | Film No.: 25990143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)